Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Faron Pharmaceuticals Logo
Faron Pharmaceuticals Growth Score
93
CB Rank
30936
Heat Score
65
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Founded
obfuscation
PublicPost-IPO Equity Turku, Western Finland, Finland11-50 www.faron.com
Biopharma
Biotechnology
Medical
Pharmaceutical
Overview

Faron Pharmaceuticals
Total Funding
obfuscation
Growth Score
93
Heat Score
65

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score93
-3 pts
in past quarter
Heat Score 65
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Faron Pharmaceuticals

CB Rank
30936
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Founded
obfuscation
PublicPost-IPO Equity Turku, Western Finland, Finland11-50 www.faron.com
Biopharma
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name Faron Pharmaceuticals Ltd
Operating Status Active
Stock Symbol  LSE:FARN
Company Type For Profit
Founders  Markku Jalkanen
About the Company
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.
Phone Number +35802469515
Contact Email info@faron.com
Predictions & Insights

Growth Insight

See this Growth Insight
Faron Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

bexmarilimab
A humanized monoclonal antibody targeting Clever-1 to reprogram myeloid cells and reduce cancer immunosuppression, under clinical investigation for hematological cancers.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 14
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 14
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of Juho Jalkanen
Juho Jalkanen
Yes
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
Photo of Juho Jalkanen
Juho Jalkanen
Yes
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
Photo of Juho Jalkanen
Juho Jalkanen
Yes
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
Photo of Juho Jalkanen
Juho Jalkanen
Yes
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
Photo of Juho Jalkanen
Juho Jalkanen
Yes
Post-IPO Equity - Faron Pharmaceuticals Logo
Post-IPO Equity - Faron Pharmaceuticals
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 6 Board Members and Advisors 3 Contacts 13

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

20,640
308.87%
 in past month

IT Spend

$496.8KThis year, Faron Pharmaceuticals is projected to spend $496.8K on IT, according to Aberdeen.

Actively Used Products

9Faron Pharmaceuticals uses 9 technology products and services including Google Fonts, GlobalSign, and  Amazon EC2, according to G2 Stack.

Active Website Tech Count

20Faron Pharmaceuticals is actively using 20 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  HSTS.

Total IP

72The intellectual property of Faron Pharmaceuticals includes 38 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Faron Pharmaceuticals has registered 34 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Faron Pharmaceuticals's headquarters? Faron Pharmaceuticals is located in Turku, Western Finland, Finland.Who invested in Faron Pharmaceuticals? Faron Pharmaceuticals has 8 investors including Juho Jalkanen and  Heights Capital Management.When was the last funding round for Faron Pharmaceuticals? Faron Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Faron Pharmaceuticals's competitors? Alternatives and possible competitors to Faron Pharmaceuticals may include Compass Therapeutics, Pyxis Oncology, and  Day One Biopharmaceuticals.How much funding has Faron Pharmaceuticals raised to date? Faron Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|